CClinicalTrials.gg
CompletedNCT02935270Updated Nov 25, 2022

Examining Measurement of Behavioral Neglect Post Stroke

An observational study in Stroke and Hemispatial Neglect, sponsored by Medical University of South Carolina. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-25.

Sponsored by Medical University of South Carolina · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
55
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to examine measurement of unilateral neglect post stroke. Although a number of clinical assessments are used to measure neglect, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure neglect. This study will determine whether these assessments measure different aspects of neglect and whether items from various neglect assessments can be combined to more effectively measure neglect.

Read the detailed description

Many individuals have difficulty attending to the affected side of their body or to the affected side of space after stroke (unilateral neglect). Although a number of clinical assessments are used to measure this inattention, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure inattention. Clinical assessments provide critical information to clinicians and researchers and are used to inform treatment and document patient progress. Therefore, it is important that investigators more closely examine these existing assessments.

Individuals who demonstrate impaired attention to the affected side after stroke also have greater motor impairment than individuals who do not have impaired attention, but investigators do not know how inattention affects reaching movements using the impaired arm. This study will examine various methods used to assess inattention to the affected side after stroke and also examine how inattention affects reaching movements of the impaired arm.

02

Conditions studied

  • Stroke
  • Hemispatial Neglect

Keywords

  • Stroke
  • Neglect
  • Rehabilitation
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 55 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stroke survivors

Inclusion criteria

  • Unilateral hemispheric stroke
  • 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Severe aphasia
  • Inability to follow 2-step directions
  • Presence of other neurological disease that may impair vision or perception during performance of evaluation procedures
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
55 participants (actual)
Patient registry
No

Groups and cohorts

  • Stroke Survivors

    Individuals who have experienced a unilateral hemispheric stroke

06

What researchers measure

Primary outcomes

  1. Catherine Bergego Scale

    Time frame: One-time assessment scheduled over 1-2 days

  2. Behavioral Inattention Test

    Time frame: One-time assessment scheduled over 1-2 days

  3. Naturalistic Action Test

    Time frame: One-time assessment scheduled over 1-2 days

  4. Virtual Reality Lateralized Attention Test

    Time frame: One-time assessment scheduled over 1-2 days

  5. Kinematic Assessment of Arm Movement

    Time frame: One-time assessment scheduled over 1-2 days

Secondary outcomes

  1. Arm Use measured by Accelerometers

    Accelerometers will be issued on the first assessment day. Participants will wear accelerometers for 3 days.

    Time frame: One-time assessment scheduled over 3 days

07

Study locations

1 site
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
08

References and documents

Publications

  • Grattan ES, Woodbury ML. Do Neglect Assessments Detect Neglect Differently? Am J Occup Ther. 2017 May/Jun;71(3):7103190050p1-7103190050p9. doi: 10.5014/ajot.2017.025015. PubMed 28422631 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02935270
Lead sponsor
Medical University of South Carolina
Responsible party
Michelle Woodbury (Post Doctoral Scholar, Medical University of South Carolina) — Principal investigator
First posted
Oct 17, 2016
Start date
Jan 2016
Primary completion
Feb 21, 2020
Completion
Feb 21, 2020
Last update
Nov 25, 2022

Study contacts

Michelle Woodbury, PhD, OTR/L
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion